EP300 and Alzheimer disease: During the development of AD, P300-mediated acetylation of histone H3, located in the promoter region of presenilin-1 (PS1) and beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) aggravated neuronal injury, whereas targeted inhibition of P300 mitigated AD symptoms and abnormal protein aggregation.